Södertälje, Sweden

Vern Delisser


 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Sodertalje, SE (2014)
  • Södertälje, SE (2012 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Vern Delisser in Amyloid Imaging

Introduction

Vern Delisser is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of medical imaging, particularly in the diagnosis of Alzheimer's disease. With a total of 4 patents to his name, Delisser's work focuses on developing compounds that enhance the imaging of amyloid deposits in living patients.

Latest Patents

Delisser's latest patents include innovative compounds that serve as precursors for imaging amyloid deposits. These novel derivatives are designed to facilitate the antemortem diagnosis of Alzheimer's disease through positron emission tomography (PET). The compounds derived from these precursors are crucial for visualizing amyloid deposits in the brain, which is essential for assessing the clinical efficacy of therapeutic agents for Alzheimer's disease. Additionally, the patents disclose the precursor compounds in crystalline form, further enhancing their utility in medical applications.

Career Highlights

Vern Delisser is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on groundbreaking research that bridges the gap between chemistry and medical diagnostics. Delisser's contributions have been instrumental in advancing the understanding and treatment of neurodegenerative diseases.

Collaborations

Throughout his career, Delisser has collaborated with esteemed colleagues, including Nils Anders Nilsson and Katinka Ruda. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of medical research.

Conclusion

Vern Delisser's innovative work in the development of compounds for imaging amyloid deposits represents a significant advancement in the diagnosis of Alzheimer's disease. His contributions continue to impact the medical field positively, paving the way for improved diagnostic techniques and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…